Resch Miklós, Szentmáry Nóra, Nagy Zoltán Zsolt, Czumbel Norbert
Semmelweis Egyetem, Altalános Orvostudományi Kar, I. Szemészeti Klinika, Budapest.
Orv Hetil. 2004 Mar 14;145(11):573-8.
To evaluate the results of photorefractive keratectomy (PRK) and Laser in situ keratomieusis (LASIK) in eyes treated with hyperopia.
group 1 consisted of PRK-operated eyes, group 2 consisted of LASIK-operated eyes. In each group 20 eyes of 20 patients were listed. The average age in Group 1 was 33.4 +/- 8.4 year, while in group 2 it was 34.2 +/- 7.9 year. Refractive treatments were carried out with the Asclepion Meditec MEL 70 G-Scan flying spot excimer laser, LASIK flaps were created by the Moria CB manual microkeratome.
In group 1, pre-operative refraction was +4.2 +/- 1.1 D (SE = spherical equivalent), in group 2 it was +4.8 +/- 1.21 D. Six months following surgery refraction was +0.35 +/- 0.12 D (SE) in group 1, while +0.38 +/- 0.14 D (SE) in group 2. The uncorrected visual acuity was 0.92 +/- 0.04 in group 1 and 0.91 +/- 0.01 in group 2.85% of eyes in group 1 and 95% of eyes in group 2 had a 1.0 uncorrected visual acuity. In group 1, 95% of the eyes were within +/- 1.0 D of targeted refraction, while in group 2, 100% achieved this. Best spectacle corrected visual acuity (BSCVA) did not change in 90% of group 1, while in 5% it increased by 1 and in the remaining 5% decreased by 1 Snellen line. In group 2. BSCVA remained unchanged in 85% of eyes, while in 10% it increased and in 5% decreased by 1 Snellen line. In group 1, glare was reported in 4 eyes, while in group 2.5 eyes reported postoperative glare, mainly during night driving.
Effectivity, predictability and safety was good in both treatment groups. Results of hyperopic eyes below +6.0 D of preoperative refraction were not dependent on the type of operation (PRK or LASIK).
评估准分子原位角膜磨镶术(LASIK)和准分子激光角膜切削术(PRK)治疗远视眼的效果。
第1组为接受PRK手术的眼睛,第2组为接受LASIK手术的眼睛。每组纳入20例患者的20只眼睛。第1组的平均年龄为33.4±8.4岁,第2组为34.2±7.9岁。屈光治疗采用德国Asclepion Meditec公司的MEL 70 G-Scan飞点式准分子激光,LASIK瓣由Moria CB手动微型角膜刀制作。
第1组术前等效球镜度(SE)为+4.2±1.1 D,第2组为+4.8±1.21 D。术后6个月,第1组的等效球镜度为+0.35±0.12 D(SE),第2组为+0.38±0.14 D(SE)。第1组的裸眼视力为0.92±0.04,第2组为0.91±0.01。第1组85%的眼睛裸眼视力为1.0,第2组为95%。第1组95%的眼睛屈光度数在目标度数±1.0 D范围内,第2组为100%。第1组90%的患者最佳矫正视力(BSCVA)未改变,5%的患者提高了1行,其余5%的患者降低了1行。第2组85%的眼睛BSCVA保持不变,10%的患者提高,5%的患者降低1行。第1组有4只眼睛出现眩光,第2组有5只眼睛术后出现眩光,主要在夜间驾车时。
两个治疗组的有效性、可预测性和安全性均良好。术前屈光不正低于+6.0 D的远视眼,其手术效果与手术方式(PRK或LASIK)无关。